Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

C. Kobe, M. Dietlein, J. Franklin, J. Markova, A. Lohri, H. Amthauer, S. Klutmann, W.H. Knapp, J.M. Zijlstra-Baalbergen, A. Bockisch, M. Weckesser, R. Lorenz, M. Schreckenberger, R. Bares, H.T. Eich, R.P. Mueller, M. Fuchs, P. Borchmann, H. Schicha, V. DiehlA. Engert

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3989-3994
JournalBlood
Volume112
Issue number10
DOIs
Publication statusPublished - 2008

Cite this